» Articles » PMID: 21994609

Virus Infection Recognition and Early Innate Responses to Non-enveloped Viral Vectors

Overview
Journal Viruses
Publisher MDPI
Specialty Microbiology
Date 2011 Oct 14
PMID 21994609
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Numerous human genetic and acquired diseases could be corrected or ameliorated if viruses are harnessed to safely and effectively deliver therapeutic genes to diseased cells and tissues in vivo. Innate immune and inflammatory response represents one of the key stumbling blocks during the development of viral-based therapies. In this review, current data on the early innate immune responses to viruses and to the most commonly used gene therapy vectors (using adenovirus and adeno-associated virus) will be discussed. Recent findings in the field may help develop new approaches to moderate these innate immune anti-viral responses and thus improve the safety of viral vectors for human gene therapy applications.

Citing Articles

Temporal insights into molecular and cellular responses during rAAV production in HEK293T cells.

Patra A, Tan E, Kok Y, Ng S, Bi X Mol Ther Methods Clin Dev. 2024; 32(3):101278.

PMID: 39022743 PMC: 11253160. DOI: 10.1016/j.omtm.2024.101278.


Global Dynamics of SARS-CoV-2 Infection with Antibody Response and the Impact of Impulsive Drug Therapy.

Chatterjee A, Al Basir F, Biswas D, Abraha T Vaccines (Basel). 2022; 10(11).

PMID: 36366355 PMC: 9699126. DOI: 10.3390/vaccines10111846.


Comprehensive computational analysis reveals H5N1 influenza virus-encoded miRNAs and host-specific targets associated with antiviral immune responses and protein binding.

Noor F, Saleem M, Javed M, Chen J, Ashfaq U, Okla M PLoS One. 2022; 17(5):e0263901.

PMID: 35533150 PMC: 9084522. DOI: 10.1371/journal.pone.0263901.


T cell receptor signaling pathway and cytokine-cytokine receptor interaction affect the rehabilitation process after respiratory syncytial virus infection.

Qian Z, Zhang Z, Wang Y PeerJ. 2019; 7:e7089.

PMID: 31223533 PMC: 6571000. DOI: 10.7717/peerj.7089.


Systemic AAV Micro-dystrophin Gene Therapy for Duchenne Muscular Dystrophy.

Duan D Mol Ther. 2018; 26(10):2337-2356.

PMID: 30093306 PMC: 6171037. DOI: 10.1016/j.ymthe.2018.07.011.


References
1.
Di Paolo N, Miao E, Iwakura Y, Murali-Krishna K, Aderem A, Flavell R . Virus binding to a plasma membrane receptor triggers interleukin-1 alpha-mediated proinflammatory macrophage response in vivo. Immunity. 2009; 31(1):110-21. PMC: 2759279. DOI: 10.1016/j.immuni.2009.04.015. View

2.
HUTCHIN M, Pickles R, Yarbrough W . Efficiency of adenovirus-mediated gene transfer to oropharyngeal epithelial cells correlates with cellular differentiation and human coxsackie and adenovirus receptor expression. Hum Gene Ther. 2000; 11(17):2365-75. DOI: 10.1089/104303400750038471. View

3.
Lozier J, Csako G, Mondoro T, Krizek D, Metzger M, Costello R . Toxicity of a first-generation adenoviral vector in rhesus macaques. Hum Gene Ther. 2002; 13(1):113-24. DOI: 10.1089/10430340152712665. View

4.
Tan Y, Hackett N, Boyer J, Crystal R . Protective immunity evoked against anthrax lethal toxin after a single intramuscular administration of an adenovirus-based vaccine encoding humanized protective antigen. Hum Gene Ther. 2003; 14(17):1673-82. DOI: 10.1089/104303403322542310. View

5.
Yamamoto M, Sato S, Mori K, Hoshino K, Takeuchi O, Takeda K . Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling. J Immunol. 2002; 169(12):6668-72. DOI: 10.4049/jimmunol.169.12.6668. View